Regarding beinaglutide, Fang et al. showed that it could reduce food intake, gastric emptying, body weight, liver function tests (LFTs), and glucose levels in a dose-dependent manner, thus improving hepatic insulin sensitivity and hepatic steatosis. Here, INS is linked to fatty liver disease.